Introduction
Recurrent herpes simplex infections around the mouth (herpes labialis, cold sores, fever blisters) occur in up to one fifth of young adults,' 2 but no treatment has hitherto been shown in double blind, placebo controlled trials to have an appreciable clinical benefit. The discovery of acyclovir (Zovirax, Wellcome), an antiviral drug with highly specific activity against herpes simplex virus types 1 and 2,3 offers the possibility of a safe and effective topical preparation for the treatment of recurrent herpes simplex virus infections. Oral acyclovir has been shown to be effective in the treatment of recurrent genital herpes,4 and topical acyclovir in an ointment base (polyethylene glycol) shortens the duration of virus shedding in patients with recurrent genital herpes5 and herpes labialis,6 without producing a demonstrable clinical benefit. The limited effect of local antiviral treatment in recurrent herpes simplex virus infections may be due to poor skin penetration of the drug, and on this account it has been suggested that acyclovir be applied using dimethyl sulphoxide as the vehicle.86 7An alternative formulation using propylene glycol as solvent has been found to be superior to acyclovir ointment for the treatment of experimental cutaneous herpes simplex virus infections in animals.8
It has been suggested that recurrent herpes labialis will complete its natural course unless specific antiviral treatment with acyclovir is initiated early, before the lesions become established.6 To achieve this, patients need to be supplied beforehand with the acyclovir cream, which should be applied at the onset of prodromal symptoms or signs. Studies of the clinical course and treatment of herpes labialis at the Wellcome Research Laboratories indicated that only about 20"0 of an otherwise healthy population experienced recurrent herpes labialis frequently or severely enough to volunteer for placebo controlled trials.9 To obtain a pool of volunteers known to suffer from recurrent herpes labialis, we approached about 5000 employees at the headquarters of the British Petroleum Company in London. We report the results of a randomised, double blind trial of acyclovir cream in subjects with a history of recurrent herpes labialis who attended the medical centre of the British Petroleum headquarters.
Patients and Methods
A brief questionnaire was sent to about 4500 employees at Britannic House. We selected 90 patients who gave a history of at least two recurrences of herpes labialis per year and were prepared to volunteer for inclusion in a controlled trial. Those lesions compared with two in the placebo group, whereas for all episodes there were five in the treated group and four in the placebo group. Acyclovir did not effect the development of new lesions but this was low in both treatment groups. In all patients the time to first formation of ulcer or crust and time to complete healing were significantly reduced in first and all episodes treated with acyclovir (table II and figure) . When the patients whose lesions aborted were excluded from the analysis then these two variables still showed trends in favour of acyclovir. For all episodes the time to healing of lesions not aborting was significantly shorter with acyclovir compared with placebo. The major symptom reported by the patients was itching, and fewer patients receiving acyclovir developed this symptom during treatment of their first episode. The total duration of all symptoms was also reduced in first episodes treated with acyclovir, though this did not quite reach significance. No other effects on symptoms were shown but symptoms did not play a major part in the course of the infections.
Two patients treated with placebo, four patients treated with acyclovir, and one patient during treatment with both acyclovir and placebo reported flaking of the skin in the area of application of the cream. A further patient receiving placebo reported stinging on application of the cream. Treatment did not have to be withdrawn from any patient.
Discussion
Other workers have reported an antiviral effect in herpes labialis with acyclovir ointment6 but even increasing the concentration of acyclovir and starting treatment A few more patients receiving acyclovir than placebo reported flaking of the skin and this may be a result of a partially aborted lesion rather than a toxic reaction. Otherwise the treatment was well tolerated.
Although formation of new lesions is rare in herpes labialis, it was observed that topical acyclovir had no effect on new lesions. This is not unexpected, as local applications were limited to the expected site of the initial lesions, but serves to illustrate one of the disadvantages of topical treatment. The use of topical treatment will also be limited in patients with multiple lesions at different sites; lesions in inaccessible places, such as the nares or in the mouth; and where compliance may be a problem, for instance with frequent or continuous usage. Oral acyclovir is effective for recurrent mucocutaneous herpes simplex infections at other sides,4 and studies evaluating the prophylactic use of oral acyclovir for frequent recurrences of herpes labialis and genital herpes are currently in progress.
For the management of recurrent herpes labialis acyclovir cream offers an effective and acceptable alternative to the unproved home remedies currently attempted. MEDICINES PROVOKING URINE-The causes by which urine is suppressed are many. 1. By too much drying, or sweating, it may be consumed. 2. By heat or inflammation of the reins or passages whereby it passes from the reins, it may be stopped by compression. Urine is the thinnest part of blood, separated from the thickest part in the reins. If then the blood be more thick and viscous than ordinary, it cannot easily be separated without cutting and cleansing medicines. This is for certain, that blood can neither be separated nor distributed without heat. Yet amongst diuretics are some cold things, as the four greater cold seeds, Winter-cherries, and the like. Although this seem a wonder, yet it may be, and doth stand with truth. For cool diureticks, though they further not the separation of the blood one jot, yet they cleanse and purge the passages of the urine. Diureticks then are of two sorts: 1. Such as conduce to the separation of the blood. 2. Such as open the urinal passages. The former are biting (and are known by their taste) very hot and cutting, whence they penetrate to the reins, and cut the gross humours there. Bitter things, although they be very hot, and cut gross humours, yet are they of a more dry and terrene substance than is convenient to provoke urine. Hence then we may safely gather, that bitter things are not so moist nor penetrating, as such as bite like Pepper. (Nicholas Culpeper (1616-54) The Complete Herbal, 1850.)
